"Methyl Methanesulfonate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An alkylating agent in cancer therapy that may also act as a mutagen by interfering with and causing damage to DNA.
Descriptor ID |
D008741
|
MeSH Number(s) |
D02.455.326.146.100.050.500.500 D02.886.645.600.055.050.510.500
|
Concept/Terms |
Methyl Methanesulfonate- Methyl Methanesulfonate
- Methanesulfonate, Methyl
- Methyl Methylenesulfonate
- Methylmesilate
- Methylmethane Sulfonate
- Mesilate, Methyl
- Methyl Mesilate
- Methyl Mesylate
- Mesylate, Methyl
|
Below are MeSH descriptors whose meaning is more general than "Methyl Methanesulfonate".
Below are MeSH descriptors whose meaning is more specific than "Methyl Methanesulfonate".
This graph shows the total number of publications written about "Methyl Methanesulfonate" by people in this website by year, and whether "Methyl Methanesulfonate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Methyl Methanesulfonate" by people in Profiles.
-
Iyer DR, Rhind N. Replication fork slowing and stalling are distinct, checkpoint-independent consequences of replicating damaged DNA. PLoS Genet. 2017 Aug; 13(8):e1006958.
-
Willis NA, Zhou C, Elia AE, Murray JM, Carr AM, Elledge SJ, Rhind N. Identification of S-phase DNA damage-response targets in fission yeast reveals conservation of damage-response networks. Proc Natl Acad Sci U S A. 2016 06 28; 113(26):E3676-85.
-
Sosna J, Voigt S, Mathieu S, Lange A, Thon L, Davarnia P, Herdegen T, Linkermann A, Rittger A, Chan FK, Kabelitz D, Sch?tze S, Adam D. TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death. Cell Mol Life Sci. 2014 Jan; 71(2):331-48.
-
Goellner EM, Grimme B, Brown AR, Lin YC, Wang XH, Sugrue KF, Mitchell L, Trivedi RN, Tang JB, Sobol RW. Overcoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repair. Cancer Res. 2011 Mar 15; 71(6):2308-17.
-
Ravi D, Wiles AM, Bhavani S, Ruan J, Leder P, Bishop AJ. A network of conserved damage survival pathways revealed by a genomic RNAi screen. PLoS Genet. 2009 Jun; 5(6):e1000527.
-
Nowosielska A, Smith SA, Engelward BP, Marinus MG. Homologous recombination prevents methylation-induced toxicity in Escherichia coli. Nucleic Acids Res. 2006; 34(8):2258-68.
-
Chahwan C, Nakamura TM, Sivakumar S, Russell P, Rhind N. The fission yeast Rad32 (Mre11)-Rad50-Nbs1 complex is required for the S-phase DNA damage checkpoint. Mol Cell Biol. 2003 Sep; 23(18):6564-73.
-
Zhan Q, Bieszczad CK, Bae I, Fornace AJ, Craig RW. Induction of BCL2 family member MCL1 as an early response to DNA damage. Oncogene. 1997 Mar 06; 14(9):1031-9.